Current position:Home >Product >
alpha-N-Acetylgalactosaminyl-(1-3)-[alpha-fucosyl-(1-2)]-beta-galactosyl-(1-4)-beta-N-acetylglucosaminyl-(1-3)-beta-galactosyl-(1-4)-glucose
alpha-N-Acetylgalactosaminyl-(1-3)-[alpha-fucosyl-(1-2)]-beta-galactosyl-(1-4)-beta-N-acetylglucosaminyl-(1-3)-beta-galactosyl-(1-4)-glucose(30461-82-6)
- Name: alpha-N-Acetylgalactosaminyl-(1-3)-[alpha-fucosyl-(1-2)]-beta-galactosyl-(1-4)-beta-N-acetylglucosaminyl-(1-3)-beta-galactosyl-(1-4)-glucose
- Synonyms:alpha-N-Acetylgalactosaminyl-(1-3)-[alpha-fucosyl-(1-2)]-beta-galactosyl-(1-4)-beta-N-acetylglucosaminyl-(1-3)-beta-galactosyl-(1-4)-glucose;Blood group A hexasaccharide type II;D-Glucose, O-2-(acetylamino)-2-deoxy-α-D-galactopyranosyl-(1→3)-O-[6-deoxy-α-L-galactopyranosyl-(1→2)]-O-β-D-galactopyranosyl-(1→4)-O-2-(acetylamino)-2-deoxy-β-D-glucopyranosyl-(1→3)-O-β-D-galactopyranosyl-(1→4)-;Blood group A antigen hexaose type 2 grafted on BSA;Blood group A antigen hexaose type 2 linked to biotin (Linker-BT A);Blood group A antigen hexaose type 2 linked to biotin (Linker-BT B);Blood group A antigen hexaose type 2 linked to biotin (Linker-BT C);Blood group A antigen hexaose type 2 linked to biotin and fluorescein (Linker-BT-FLUO A)
- Molecular Formula:C40H68N2O30
- Molecular Weight:1056.97
- CAS Registry Number:30461-82-6
- EINECS:
- Melting Point:1440.8±65.0 °C(Predicted)
- Water Solubility:
Other Product
- 304480-54-4/N'-(2-hydroxy-3-methoxybenzylidene)-4-biphenylcarbohydrazide
- 304480-70-4/2-methoxy-4-[2-(3-nitrobenzoyl)carbonohydrazonoyl]phenyl acetate
- 304481-12-7/4-[(2-methyl-3-nitrophenyl)amino]-4-oxobutanoic acid
- 304481-16-1/2-(5-bromo-2-thienyl)-1,3-diphenylimidazolidine
- 304481-31-0/2-[(2-hydroxy-4,4-dimethyl-6-oxocyclohex-1-en-1-yl)(5-methylfuran-2-yl)methyl]-5,5-dimethylcyclohexane-1,3-dione
- 304481-46-7/N',N''-[1,4-phenylenedi(methylylidene)]bis(3,4-dihydroxybenzohydrazide)
- 304481-64-9/N'-[(9-ethyl-9H-carbazol-2-yl)methylene]-2,4-dihydroxybenzohydrazide
- 304481-72-9/2,4-Dihydroxy-N'-(2-hydroxy-5-nitrobenzylidene)benzohydrazide
- 304481-74-1/N'-(2,3-dichlorobenzylidene)-3,4-dihydroxybenzohydrazide
- 304481-79-6/4-[2-(2-methylbenzoyl)hydrazino]-4-oxobutanoic acid
- 304481-84-3/methyl 5-benzyl-2-[(6-{[5-benzyl-3-(methoxycarbonyl)-4-methyl-2-thienyl]amino}-6-oxohexanoyl)amino]-4-methyl-3-thiophenecarboxylate
- 304481-87-6/diethyl 2,2'-[(1,6-dioxo-1,6-hexanediyl)di(imino)]bis(4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylate)
- 304508-62-1/N-[2-(morpholin-4-yl)ethyl]thiophene-2-carboxamide
- 304510-03-0/5-bromo-N-(5-methylthiazol-2-yl)furan-2-carboxamide
- 3045-11-2/2,5-Benzodiazocine, 1-(4-chlorophenyl)-1,2,3,4,5,6-hexahydro-, dihydrochloride, (+)- (9CI)
- 30455-73-3/2-Benzofuranethanamine, α-methyl-
- 30461-25-7/(3R,4S)-4-aminothiolan-3-ol hydrobromide
- 3046141-72-1/2,6-Dimethyl-γ-pyrone
- 3046142-41-7/0
- 30461-82-6/alpha-N-Acetylgalactosaminyl-(1-3)-[alpha-fucosyl-(1-2)]-beta-galactosyl-(1-4)-beta-N-acetylglucosaminyl-(1-3)-beta-galactosyl-(1-4)-glucose
- 30461-92-8/(6aR,12aα)-2-Hydroxy-3-methoxy-6a,12a-dihydro-6H-[1,3]dioxolo[5,6]benzofuro[3,2-c][1]benzopyran
- 3046226-91-6/(E)-3-(2-aminoethyl)-2-(mesitylimino)-9,10-dimethoxy-2,3,6,7-tetrahydro-4H-pyrimido[6,1-a]isoquinolin-4-one
- 3046309-16-1/4-(3,6-Dimethyl-9H-carbazol-9-yl)phenyl]phosphonic Acid
- 3046309-17-2/MeO-PhPACz
- 3046309-18-3/(4-(7H-dibenzo[c,g]carbazol-7-yl)phenyl)phosphonic acid
- 3046390-26-2/isopropyl (S)-2-amino-3-((S)-2-oxopyrrolidin-3-yl)propanoate hydrochloride
- 3046390-84-2/5-[[2-hydroxy-5-methyl-3-[(2，4，5-trihydroxyphenyl)methyl]phenyl]methyl]benzene-1，2，4-triol
- 3046422-18-5/Benzoxazole, 6-nitro-2-(tetrahydro-1H-furo[3,4-c]pyrrol-5(3H)-yl)-
- 304642-91-9/Flagelin22
- 304646-49-9/2-(2-hydroxyphenoxy)acetohydrazide